NASDAQ:SLS   SELLAS Life Sciences Group, Inc.
SLS was sold off hard the last two days despite positive news. The current price has acted as both support and resistance in recent months (shaded area).

With an RSI of 38 and the price well bellow the POC line (90 days) I think 9.08 may have been the bottom. I think the drop had more to do with large investors rebalancing for the 2nd half of the year than anything else.

I would like to see the price close above the 50SMA to enter for a long swing trade.

Targeting 12.89 in the short term.

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.